Miklós Tóth

Miklós Tóth

Auto-generated profile, based on publicly available information

Miklós Tóth

Semmelweis Egyetem Belgyógyászati és Onkológiai Klinika

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2013 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
MTMiklós Tóth
Miklós Tóth
AGAshley Grossman
Ashley Grossman

28 November 2007 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
LFL. Fütő
L. Fütő
JTJ. Tőke
J. Tőke
APAttila Patocs
Attila Patocs
ÁSÁ. Szappanos
Á. Szappanos
IVI. Varga
I. Varga
MTM. Tóth
M. Tóth

10 June 2009 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
ÁSÁ. Szappanos
Á. Szappanos
JTJ. Tőke
J. Tőke
DLD. Lippai
D. Lippai
APAttila Patocs
Attila Patocs
Peter IgazPeter Igaz
Peter Igaz
MTM. Tóth
M. Tóth

5 October 2009 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
ÁSÁgnes Szappanos
Ágnes Szappanos
APAttila Patocs
Attila Patocs
JTJudit Tõke
Judit Tõke
BBBelema Boyle
Belema Boyle
MSMárta Sereg
Márta Sereg
MTMiklós Tóth
Miklós Tóth

1 April 2011 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
RSRéka Skoumal
Réka Skoumal
MTMiklós Tóth
Miklós Tóth
RSRaisa Serpi
Raisa Serpi
JRJaana Rysä
Jaana Rysä
HLHanna Leskinen
Hanna Leskinen
RKRisto Kerkelä
Risto Kerkelä

6 March 2018 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
ÁMÁgnes Molnár
Ágnes Molnár
APAttila Patocs
Attila Patocs
ILIstvan Liko
Istvan Liko
GNGábor Nyírő
Gábor Nyírő
KRKároly Rácz
Károly Rácz
BSBeatrix Sármán
Beatrix Sármán
Glucocorticoid resistance is a rare, sporadic or familial condition caused by mutation of the gene encoding the glucocorticoid receptor (GR). Clinically it is characterized by symptoms developed due to local, tissue-specific, or generalized partial insensitivity to glucocorticoids. A 31-year-old woman was evaluated because of infertility at the Endocrine Unit of the 2nd Department of Medicine, Semmelweis University. During her laboratory investigations, elevated serum and salivary cortisol were observed which failed to be suppressed after administration of 1 mg dexamethasone. 24 h urinary cortisol was increased, but a normal midnight serum cortisol was detected suggesting a maintained circadian rhythm. Plasma dehydroepiandrosterone-sulfate and androstendione levels were also elevated. Repeated plasma ACTH measurements indicated slightly elevated or normal values. Bone mineral density was normal. All laboratory results confirmed the diagnosis of glucocorticoid resistance. Genetic counseling followed by Sanger sequencing of the coding region of the gene encoding human glucocorticoid receptor was performed and a missense mutation (Arg714Gln, R714Q) in a heterozygous form was detected. Following family screening, the same mutation was found in her clinically-healthy 35-year-old sister who had no fertility problems.This variant was not detected in more than 60 patients and controls tested either for glucocorticoid resistance or Cushing’s syndrome in our Laboratory and it was absent in Exome Variant Server, HumanGene Mutation Database and ExAC databases. Our case fulfils the diagnostic criteria of glucocorticoid resistance, also named Chrousos syndrome. The glucocorticoid receptor gene mutation detected in our patient has been already reported in a 2-year-old child with hypoglycaemia, hypokalaemia, hypertension and premature puberty. These distinct phenotypes may suggest that other factors may modify the functional consequences of the R714Q variant of GR.